[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ipharmacenter ipharmacenter ipharmacenter posts on X about novartis, $4503t, breaking news, pharma the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::982887414841556997/interactions)  - X Month XXX +636% - X Months XXXXX -XX% - X Year XXXXX -XXXX% ### Mentions: XX [#](/creator/twitter::982887414841556997/posts_active)  - X Month XX +600% - X Months XX -XX% - X Year XX -XX% ### Followers: XXX [#](/creator/twitter::982887414841556997/followers)  - X Month XXX +0.78% - X Months XXX -XXXX% - X Year XXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::982887414841556997/influencer_rank)  ### Social Influence [#](/creator/twitter::982887414841556997/influence) --- **Social category influence** [stocks](/list/stocks) **Social topic influence** [novartis](/topic/novartis) #12, [$4503t](/topic/$4503t) #5, [breaking news](/topic/breaking-news), [pharma](/topic/pharma) **Top assets mentioned** [Novartis AG (NVS)](/topic/novartis) ### Top Social Posts [#](/creator/twitter::982887414841556997/posts) --- Top posts by engagements in the last XX hours "#NovoNordisk Acquires #AkeroTherapeutics for $XXX Billion Expanding Its #MASH Portfolio with First-in-Class FGF21 Analogue #pharma #breaking #breakingnews #news #media #pharmaceutical #healthcare" [X Link](https://x.com/ipharmacenter/status/1978679911624655322) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-16T04:30Z XXX followers, XX engagements "#Enhertu Delivers Major Reduction in Disease Recurrence Risk for High-Risk HER2-Positive Early #BreastCancer #Pharma #pharmaceutical #healthcare #ESMO25 #ESMO2025 #ESMO #breakingnews #breaking #news #cancer #ESMOUpdates #ESMONews #ESMOAmbassadors" [X Link](https://x.com/ipharmacenter/status/1979772483021766931) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-19T04:51Z XXX followers, XXX engagements "#ESMO2025 is dominated by latest updates from #Merck #AstraZeneca #Pfizer and #JohnsonandJohnson #ESMO25 #ESMO2025 #ESMOwithiPharmaCenter #CancerResearch #Oncologist #OncoAlert #OncoAlertTopTweet #ESMOAmbassadors #immunotherapy #JohnsonandJohnson" [X Link](https://x.com/ipharmacenter/status/1980152261319004560) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-20T06:01Z XXX followers, XX engagements "#Pfizers #Braftovi and #Mektovi Combination Shows Impressive Four-Year Survival in Advanced #LungCancer Patients #ESMO25 #ESMO2025 #ESMOUpdates #news #media #breaking #pharma #pharmaceutical #ESMOAmbassadors" [X Link](https://x.com/ipharmacenter/status/1980537653461467368) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T07:32Z XXX followers, XX engagements "Find all #ESMO25 updates of major #pharmaceutical companies at one place on @ipharmacenter #ESMO2025 #ESMOAmbassadors #immunotherapy #pfizer #novartis #astrazeneca #johnsonandjohnson #astellas #merck #BMS" [X Link](https://x.com/ipharmacenter/status/1980540251014857177) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T07:42Z XXX followers, XXX engagements "Several companies have provided updates for drugs that are in development for #bladdercancer at #ESMO25 #Roche presented data of #Tecentriq #Pfizer & #Merck presented the perioperative data of #Keytruda + #Padcev combination Find details here #ESMo2025" [X Link](https://x.com/ipharmacenter/status/1980674362329252263) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T16:35Z XXX followers, XX engagements "#AstraZeneca presenting multiple trial outcomes at #ESMO25 Fill the latest updates on @ipharmacenter #ESMO2025 updates here:" [X Link](https://x.com/ipharmacenter/status/1979773804160364847) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-19T04:57Z XXX followers, XXX engagements "#Novartis #Pluvicto Shows Significant Delay in Disease Progression in Metastatic #ProstateCancer #ESMO25 #ESMO2025 #ESMOAmbassadors #OncoAlert #OncoAltertTopTweet #Cancer #CancerResearch #Berlin" [X Link](https://x.com/ipharmacenter/status/1980509486222831736) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T05:40Z XXX followers, XX engagements "#Xtandi Plus #Leuprolide Cuts Risk of Death by XX% in Advanced #ProstateCancer Delivering 8-Year Survival Benefit #ESMO25 #ESMO2025 #Pfizer #pharma #pharmaceutical #ESMOAmbassadors #Astellas" [X Link](https://x.com/ipharmacenter/status/1980534244800856314) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T07:18Z XXX followers, XX engagements "#Breastcancer updates at #ESMO2025 #AstraZenecas #Datroway showed survival benefit in TNBC #Enhertu showed benefits in eBC #Novartis #Kisqali showed disease recurrence in eBC #lillys #Verzenio showed long-term survival benefit #ESMO25 #OncoAlert" [X Link](https://x.com/ipharmacenter/status/1980675281460556163) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T16:39Z XXX followers, XX engagements "#Merck's #Keytruda shows meaningful survival benefits for an #immunotherapy-based approach in this challenging #ovariancancer population #ESMO2025 #ESMO25 #OncoAlerts #OncoAlert #Pharma #pharmaceutical #healthcare" [X Link](https://x.com/ipharmacenter/status/1980695566947373389) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T17:59Z XXX followers, XX engagements "AstraZeneca presented data Tecentriq with ctDNA testing. If approved it could mark a new era of precision medicine in bladder cancer management #ESMO25 #ESMO2025 #OncoAlert #Oncoalerts #ESMODailyReporter #cancer #pharma #pharmaceutical" [X Link](https://x.com/ipharmacenter/status/1980696260467388675) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T18:02Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ipharmacenter ipharmacenteripharmacenter posts on X about novartis, $4503t, breaking news, pharma the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks
Social topic influence novartis #12, $4503t #5, breaking news, pharma
Top assets mentioned Novartis AG (NVS)
Top posts by engagements in the last XX hours
"#NovoNordisk Acquires #AkeroTherapeutics for $XXX Billion Expanding Its #MASH Portfolio with First-in-Class FGF21 Analogue #pharma #breaking #breakingnews #news #media #pharmaceutical #healthcare"
X Link @ipharmacenter 2025-10-16T04:30Z XXX followers, XX engagements
"#Enhertu Delivers Major Reduction in Disease Recurrence Risk for High-Risk HER2-Positive Early #BreastCancer #Pharma #pharmaceutical #healthcare #ESMO25 #ESMO2025 #ESMO #breakingnews #breaking #news #cancer #ESMOUpdates #ESMONews #ESMOAmbassadors"
X Link @ipharmacenter 2025-10-19T04:51Z XXX followers, XXX engagements
"#ESMO2025 is dominated by latest updates from #Merck #AstraZeneca #Pfizer and #JohnsonandJohnson #ESMO25 #ESMO2025 #ESMOwithiPharmaCenter #CancerResearch #Oncologist #OncoAlert #OncoAlertTopTweet #ESMOAmbassadors #immunotherapy #JohnsonandJohnson"
X Link @ipharmacenter 2025-10-20T06:01Z XXX followers, XX engagements
"#Pfizers #Braftovi and #Mektovi Combination Shows Impressive Four-Year Survival in Advanced #LungCancer Patients #ESMO25 #ESMO2025 #ESMOUpdates #news #media #breaking #pharma #pharmaceutical #ESMOAmbassadors"
X Link @ipharmacenter 2025-10-21T07:32Z XXX followers, XX engagements
"Find all #ESMO25 updates of major #pharmaceutical companies at one place on @ipharmacenter #ESMO2025 #ESMOAmbassadors #immunotherapy #pfizer #novartis #astrazeneca #johnsonandjohnson #astellas #merck #BMS"
X Link @ipharmacenter 2025-10-21T07:42Z XXX followers, XXX engagements
"Several companies have provided updates for drugs that are in development for #bladdercancer at #ESMO25 #Roche presented data of #Tecentriq #Pfizer & #Merck presented the perioperative data of #Keytruda + #Padcev combination Find details here #ESMo2025"
X Link @ipharmacenter 2025-10-21T16:35Z XXX followers, XX engagements
"#AstraZeneca presenting multiple trial outcomes at #ESMO25 Fill the latest updates on @ipharmacenter #ESMO2025 updates here:"
X Link @ipharmacenter 2025-10-19T04:57Z XXX followers, XXX engagements
"#Novartis #Pluvicto Shows Significant Delay in Disease Progression in Metastatic #ProstateCancer #ESMO25 #ESMO2025 #ESMOAmbassadors #OncoAlert #OncoAltertTopTweet #Cancer #CancerResearch #Berlin"
X Link @ipharmacenter 2025-10-21T05:40Z XXX followers, XX engagements
"#Xtandi Plus #Leuprolide Cuts Risk of Death by XX% in Advanced #ProstateCancer Delivering 8-Year Survival Benefit #ESMO25 #ESMO2025 #Pfizer #pharma #pharmaceutical #ESMOAmbassadors #Astellas"
X Link @ipharmacenter 2025-10-21T07:18Z XXX followers, XX engagements
"#Breastcancer updates at #ESMO2025 #AstraZenecas #Datroway showed survival benefit in TNBC #Enhertu showed benefits in eBC #Novartis #Kisqali showed disease recurrence in eBC #lillys #Verzenio showed long-term survival benefit #ESMO25 #OncoAlert"
X Link @ipharmacenter 2025-10-21T16:39Z XXX followers, XX engagements
"#Merck's #Keytruda shows meaningful survival benefits for an #immunotherapy-based approach in this challenging #ovariancancer population #ESMO2025 #ESMO25 #OncoAlerts #OncoAlert #Pharma #pharmaceutical #healthcare"
X Link @ipharmacenter 2025-10-21T17:59Z XXX followers, XX engagements
"AstraZeneca presented data Tecentriq with ctDNA testing. If approved it could mark a new era of precision medicine in bladder cancer management #ESMO25 #ESMO2025 #OncoAlert #Oncoalerts #ESMODailyReporter #cancer #pharma #pharmaceutical"
X Link @ipharmacenter 2025-10-21T18:02Z XXX followers, XX engagements
/creator/twitter::ipharmacenter